MARC details
| 000 -LEADER |
|---|
| fixed length control field |
07568pam a22003374a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240222150140.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
050217s2002 paua 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2005271741 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0683302655 (pbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780683302653 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BUL |
| Transcribing agency |
BUL |
| Modifying agency |
BUL |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
QZ 18.2 S358p 2002 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.07076 |
| Edition number |
22 |
| Item number |
SCH |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Schneider, Arthur S. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pathology / |
| Statement of responsibility, etc. |
Arthur S. Schneider, Philip A. Szanto. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Philadelphia : |
| Name of publisher, distributor, etc. |
Lippincott/Williams & Wilkins ; |
| Date of publication, distribution, etc. |
c2002. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvii, 470 p. : |
| Other physical details |
ill. ; |
| Dimensions |
26 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Board review series |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes index : p. 451 - 470 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Contents<br/>1 Cellular Reaction to Injury 1<br/><br/>I Adaptation to Environmental Stress 1<br/><br/>II Hypoxic Cell Injury 3<br/><br/>III Free Radical Injury 4<br/><br/>IV Chemical Cell Injury 4<br/><br/>V Necrosis 5<br/><br/>VI Apoptosis 6<br/><br/>VII Reversible Cellular Changes and Accumulations 8<br/><br/>VIII Disorders Characterized by Abnormalities of Protein Folding 11<br/><br/>Review Test 12<br/><br/>2 Inflammation 17<br/><br/>I Introduction 17<br/><br/>II Acute Inflammation 17<br/><br/>III Chronic Inflammation 24<br/><br/>IV Tissue Repair 26<br/><br/>Review Test 28<br/><br/>3 Hemodynamic Dysfunction 33<br/><br/>I Hemorrhage 33<br/><br/>II Hyperemia 33<br/><br/>III Infarction 34<br/><br/>IV Thrombosis 34<br/><br/>V Embolism 39<br/><br/>VI Edema 40<br/><br/>VII Shock 41<br/><br/>Review Test 43<br/><br/>4 Genetic Disorders 48<br/><br/>I Chromosomal Disorders 48<br/><br/>II Modes of Inheritance of Monogenic Disorders 52<br/><br/>III Mendelian Disorders 53<br/><br/>IV Balanced Polymorphism 60<br/><br/>V Polygenic and Multifactorial Disorders 60<br/><br/>VI Disorders of Sexual Differentiation 61<br/><br/>Review Test 62<br/><br/>5 Immune Dysfunction 67<br/><br/>I Cells of the Immune System 67<br/><br/>II Cytokines 68<br/><br/>III Complement System 68<br/><br/>IV Human Leukocyte Antigen System 69<br/><br/>V Innate versus Acquired Immunity 69<br/><br/>VI Mechanisms of Immune Injury 69<br/><br/>VII Transplantation Immunology 72<br/><br/>VIII Immunodeficiency Diseases 73<br/><br/>IX Autoimmunity 76<br/><br/>X Connective Tissue (Collagen) Diseases 77<br/><br/>XI Amyloidosis 80<br/><br/>Review Test 82<br/><br/>6 Neoplasia 87<br/><br/>I General Considerations 87<br/><br/>II Classification and Nomenclature of Tumors 87<br/><br/>III Properties of Neoplasms 89<br/><br/>IV Carcinogenesis and Etiology 92<br/><br/>V Other Neoplastic Disorders with Known DNA Defects 97<br/><br/>VI Grading and Staging 98<br/><br/>Review Test 99<br/><br/>7 Environmental Pathology 103<br/><br/>I Physical Injury 103<br/><br/>II Chemical Abuse 105<br/><br/>III Environmental Chemical Injuries 107<br/><br/>IV Adverse Effects of Therapeutic Drugs 108<br/><br/>Review Test 110<br/><br/>8 Nutritional Disorders 114<br/><br/>I Malnutrition 114<br/><br/>II Vitamins 114<br/><br/>III Obesity 118<br/><br/>Review Test 119<br/><br/>9 Vascular System 123<br/><br/>I Arterial Disorders 123<br/><br/>II Venous Disorders 127<br/><br/>III Tumors of Bloodvessels 127<br/><br/>IV Vasculitis Syndromes (Vasculitides) 128<br/><br/>V Functional Vascular Disorders 130<br/><br/>VI Hypertension 130<br/><br/>Review Test 133<br/><br/>10 The Heart 137<br/><br/>I Ischemic Heart Disease (IHD) 137<br/><br/>II Rheumatic Fever 139<br/><br/>III Other Forms of Endocarditis 141<br/><br/>IV Valvular Heart Disease 142<br/><br/>V Congenital Heart Disease 143<br/><br/>VI Diseases of the Myocardium 145<br/><br/>VII Diseases of the Pericardium 146<br/><br/>VIII Tumors of the Heart 147<br/><br/>IX Congestive Heart Failure 147<br/><br/>X Hypertrophy of the Heart 148<br/><br/>Review Test 150<br/><br/>11 Anemia 155<br/><br/>I General Concepts 155<br/><br/>II Acute Posthemorrhagic Anemia 155<br/><br/>III Iron Deficiency Anemia 155<br/><br/>IV Megaloblastic Anemias 157<br/><br/>V Anemia of Chronic Disease 159<br/><br/>VI Aplastic Anemia 159<br/><br/>VII Myelophthisic Anemia 160<br/><br/>VIII Hemolytic Anemias 160<br/><br/>Review Test 167<br/><br/>12 Neoplastic and Proliferative Disorders of the Hematopoietic and Lymphoid Systems 172<br/><br/>I Leukemia 172<br/><br/>II Myeloproliferative Diseases 175<br/><br/>III Non-Neoplastic Lymphoid Proliferations 177<br/><br/>IV Plasma Cell Disorders 177<br/><br/>V Lymphoid Neoplasms 179<br/><br/>Review Test 186<br/><br/>13 Hemorrhagic Disorders 192<br/><br/>I Disorders of Primary Hemostasis 192<br/><br/>II Disorders of Secondary Hemostasis 194<br/><br/>III Combined Primary and Secondary Hemostatic Defects 195<br/><br/>Review Test 197<br/><br/>14 Respiratory System 201<br/><br/>I Disorders of the Upper Respiratory Tract 201<br/><br/>II Tumors of the Upper Respiratory Tract 201<br/><br/>III Chronic Obstructive Pulmonary Disease (COPD) 202<br/><br/>IV Restrictive Pulmonary Disease 205<br/><br/>V Pulmonary Vascular Disease 210<br/><br/>VI Pulmonary Infection 211<br/><br/>VII Miscellaneous Disorders of the Lungs 215<br/><br/>VIII Cancers of the Lung 215<br/><br/>Review Test 219<br/><br/>15 Gastrointestinal Tract 225<br/><br/>I Diseases of the Mouth and Jaw 225<br/><br/>II Diseases of the Salivary Glands 226<br/><br/>III Diseases of the Esophagus 228<br/><br/>IV Diseases of the Stomach 230<br/><br/>V Diseases of the Small Intestine 232<br/><br/>VI Diseases of the Colon 236<br/><br/>VII Diseases of the Appendix 240<br/><br/>Review Test 241<br/><br/>16 Liver, Gallbladder, and Exocrine Pancreas 247<br/><br/>I Diseases of the Liver 247<br/><br/>II Diseases of the Gallbladder 255<br/><br/>III Diseases of the Exocrine Pancreas 256<br/><br/>Review Test 258<br/><br/>17 Kidney and Urinary Tract 264<br/><br/>I Congenital Anomalies of the Urinary Tract 264<br/><br/>II Glomerular Diseases 264<br/><br/>III Urinary Tract Obstruction 269<br/><br/>IV Infection of the Urinary Tract and Kidney 270<br/><br/>V Tubular and Interstitial Disorders of the Kidney 270<br/><br/>VI Diffuse Cortical Necrosis 272<br/><br/>VII Nephrocalcinosis 272<br/><br/>VIII Urolithiasis 273<br/><br/>IX Cystic Diseases of the Kidney 273<br/><br/>X Renal Failure 274<br/><br/>XI Nonrenal Causes of Azotemia 274<br/><br/>XII Tumors of the Kidney, Urinary Tract, and Bladder 275<br/><br/>Review Test 278<br/><br/>18 Male Reproductive System 287<br/><br/>I Diseases of the Penis 287<br/><br/>II Diseases of the Testes 288<br/><br/>III Diseases of the Prostate 291<br/><br/>Review Test 293<br/><br/>19 Female Reproductive System and Breast 297<br/><br/>I Vulva and Vagina 297<br/><br/>II Uterine Cervix 300<br/><br/>III Uterine Corpus 301<br/><br/>IV Fallopian Tubes 303<br/><br/>V Ovaries 304<br/><br/>VI Disorders of Pregnancy 308<br/><br/>VII Breast 310<br/><br/>Review Test 313<br/><br/>20 Endocrine System 320<br/><br/>I Pituitary 320<br/><br/>II Thyroid Gland 322<br/><br/>III Parathyroid Glands 327<br/><br/>IV Adrenal Glands 328<br/><br/>V Endocrine Pancreas 331<br/><br/>VI Multiple Endocrine Neoplasia (MEN) Syndromes 334<br/><br/>Review Test 335<br/><br/>21 Skin 342<br/><br/>I Terminology Relating to Skin Diseases 342<br/><br/>II Inflammatory and Vesicular Lesions 342<br/><br/>III Disorders of Pigmentation 344<br/><br/>IV Disorders of Viral Origin 345<br/><br/>V Miscellaneous Skin Disorders 345<br/><br/>VI Skin Malignancies 347<br/><br/>Review Test 349<br/><br/>22 Musculoskeletal System 353<br/><br/>I Diseases of Skeletal Muscle 353<br/><br/>II Diseases of Bone 355<br/><br/>III Diseases of Joints 361<br/><br/>IV Soft Tissue Tumors 364<br/><br/>Review Test 366<br/><br/>23 Nervous System 371<br/><br/>I Congenital Disorders 371<br/><br/>II Cerebrovascular Disease 372<br/><br/>III Head Injuries 373<br/><br/>IV Infections 374<br/><br/>V Demyelinating Diseases 378<br/><br/>VI Degenerative Diseases 379<br/><br/>VII Tumors 383<br/><br/>VIII Ocular Disorders 385<br/><br/>Review Test 387<br/><br/>24 Interpretation of Diagnostic Tests: Laboratory Statistics 392<br/><br/>I General Considerations 392<br/><br/>II Sensitivity and Specificity 392<br/><br/>III Positive and Negative Predictive Values 393<br/><br/>IV Variation 394<br/><br/>Review Test 395<br/><br/>Comprehensive Examination 399. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pathology |
| Form subdivision |
Outlines, syllabi, etc. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pathology |
| Form subdivision |
Examinations, questions, etc. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Szanto, Philip A. |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0829/2005271741-d.html">http://www.loc.gov/catdir/enhancements/fy0829/2005271741-d.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
origcop |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book Open Access |
| Edition |
2nd edition |
| Classification part |
QZ 18.2 |
| Item part |
1 |
| Call number prefix |
S358 2002 |
| Call number suffix |
QZ 18.2 S358 2002 |
